{"id":"W4383873053","doi":"10.1007/s00277-023-05321-3","title":"Correction to: RE‑MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola‑BR), CAR‑T therapies, and lenalidomide/rituximab (R2) based on real‑world data in patients with relapsed/refractory diffuse large B‑cell lymphoma","year":2023,"lang":"en","type":"erratum","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"","keywords":"Lenalidomide; Rituximab; Medicine; Bendamustine; Internal medicine; Oncology; Hematology; Multiple myeloma; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006690502,0.002126522,0.002408853,0.002526195,0.001713308,0.003808864,0.002864353,0.006131975,0.0244636],"category_scores_gemma":[0.08604423,0.001058892,0.002443335,0.001815268,0.001720618,0.0016269,0.001000914,0.01202447,0.01182697],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003975679,"about_ca_system_score_gemma":0.005556553,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01059371,"about_ca_topic_score_gemma":0.01079026,"domain_scores_codex":[0.9948113,0.001315188,0.001166423,0.0005656977,0.001758623,0.0003827264],"domain_scores_gemma":[0.9565439,0.01931529,0.002465765,0.001266689,0.01857155,0.001836736],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008227795,0.00000726885,0.00005726053,0.0001443783,0.00002383041,0.000164233,0.00001543688,0.00003853555,0.00003163647,0.0002433724,0.9960915,0.003100202],"study_design_scores_gemma":[0.0004433372,0.00007760135,0.001221264,0.001053884,0.0002174664,0.001121874,0.0001050954,0.0005564506,0.0004997014,0.001720754,0.9929172,0.00006547283],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.0001709896,0.001106802,0.000309975,0.07213001,0.9244844,0.00002811441,0.000614754,0.0001282977,0.001026674],"genre_scores_gemma":[0.01150387,0.007078629,0.003385289,0.1837817,0.7360835,0.0002595366,0.001526302,0.0007400374,0.05564109],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.0244636,"threshold_uncertainty_score":0.08183885,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05545757967693467,"score_gpt":0.3349910501075204,"score_spread":0.2795334704305858,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}